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Abstract
Background: The results of clinical trials should be assessed for both statistical significance and importance of
observed effects to patients. Minimal important difference (MID) is a threshold denoting a difference that is
important to patients. Patient acceptable symptom state (PASS) is a threshold above which patients feel well.
Objective: To determine MID and PASS for common outcome instruments in patients with subacromial pain
syndrome (SAPS).
Methods: We used data from the FIMPACT trial, a randomised controlled trial of treatment for SAPS that included
193 patients. The outcomes were shoulder pain at rest and on arm activity, both measured with the 0–100 mm
visual analogue scale (VAS), the Constant-Murley score (CS), and the Simple Shoulder Test (SST). The transition
question was a five-point global rating of change. We used three anchor-based methods to determine the MID for
improvement: the receiver operating characteristic (ROC) curve, the mean difference of change and the mean
change methods. For the PASS, we used the ROC and 75th percentile methods and calculated estimates using two
different anchor question thresholds.
Results: Different MID methods yielded different estimates. The ROC method yielded the smallest estimates for
MID: 20 mm for shoulder pain on arm activity, 10 points for CS and 1.5 points for SST, with good to excellent
discrimination (areas under curve (AUCs) from 0.86 to 0.94). We could not establish a reliable MID for pain at rest.
The PASS estimates were consistent between methods. The ROC method PASS thresholds using a conservative
anchor question threshold were 2 mm for pain at rest, 9 mm for pain on activity, 80 points for CS and 11 points for
SST, with AUCs from 0.74 to 0.83.
(Continued on next page)
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: simo.taimela@helsinki.fi
†Kari Kanto and Tuomas Lähdeoja contributed equally to this work.
2Finnish Centre for Evidence-Based Orthopaedics (FICEBO), Department of
Orthopaedics and Traumatology, University of Helsinki and Helsinki University
Hospital, Topeliuksenkatu 5, HUS, 00029 Helsinki, Finland
Full list of author information is available at the end of the article
Kanto et al. BMC Medical Research Methodology           (2021) 21:45 
https://doi.org/10.1186/s12874-021-01241-w
(Continued from previous page)
Conclusion: We recommend the smallest estimate from different methods as the MID, because it is very unlikely
that changes smaller than the smallest MID estimate are important to patients: 20 mm for pain VAS on arm activity,
10 points for CS and 1.5 points for SST. We recommend PASS estimates of 9 mm for pain on arm activity, 80 points
for CS, and 11 points for SST.
Trial registration: ClinicalTrials.gov NCT00428870 (first registered January 29, 2007).
Keywords: Clinimetrics, minimal important change, MID, MCID, patient accepted symptom state, PASS,
responsiveness, Outcome measures, Visual analogue scale (VAS), Simple shoulder test, Constant-Murley score, Pain,
Subacromial pain
Background
The efficacy of interventions is often measured as the
mean difference between intervention and control
groups, or the differences in proportions of patients who
achieve a desired state. It is important to judge whether
a difference is important to patients, instead of relying
on statistical significance testing to draw conclusions
about the importance of research results. To assess
whether a desired state has been achieved for an individ-
ual patient, continuous outcomes must be dichotomised
to “success” and “non-success”. In most orthopaedic
conditions, the outcomes most important to patients are
assessed with patient-reported outcome measures
(PROMs), which measure pain, function or (disease-re-
lated) quality of life. Important questions remain about
their interpretation. In particular, how a certain change
in PROM score is perceived by the patients, or at what
level of a PROM patients consider themselves well. Con-
cepts like MID and PASS have been developed to better
understand how PROM scores reflect patients’ percep-
tions of their pain or disability.
The minimal important difference, MID [1], reflects
the threshold at which a difference in a continuous out-
come is important to patients, either between groups re-
ceiving different treatments or within-group at different
time points. It is the smallest difference in the outcome
of interest that informed patients or informed proxies
perceive important enough to convince the patient and/
or clinician to choose one treatment over another [2].
MID is commonly used to help interpret the clinical im-
portance of the results of a trial or a meta-analysis and
inform calculations of numbers needed to treat (NNTs)
and sample size estimation. The MID is commonly cal-
culated using intra-individual change in outcomes over
time by anchor-based methods. In the anchor-based ap-
proach, the MID is established by relating a difference in
PROM scores to a small, but important improvement or
deterioration captured by an independent measure (ex-
ternal anchor) that is itself, interpretable. MID estimates
for a given outcome can vary depending on assessment
methods and patient populations [3–6].
Another measure that can help to interpret study re-
sults is the patient acceptable symptom state (PASS).
The PASS is the highest symptom level at which patients
consider themselves well [7]. Improving by at least MID
measures “feeling better,” whereas reaching the level of
at least PASS reflects “feeling good.” A patient reaching
PASS would typically indicate therapeutic success at the
individual level. PASS provides a tool for standardising
responder rates in clinical trials. The MID and PASS
concepts are complementary. For example, with values
MID of 20 mm and PASS of 20 mm, if an intervention
leads to a decrease of pain from VAS 80mm to VAS 50
mm, the change is important to the patient (concept of
MID) but the patient did not reach a satisfactory state
(concept of PASS). Results of a trial could be expressed
both as a proportion of improved patients and of pa-
tients in a satisfactory state. The definition of the PASS
is anchored to the personal experience of the patient
feeling well or not, and the PASS threshold for each out-
come instrument of interest can be calculated using this
answer as an external anchor.
Subacromial pain syndrome (SAPS) is the most com-
mon shoulder condition [8–10]. Despite the high preva-
lence of SAPS, only limited and almost exclusively low
credibility data exist on MID and PASS thresholds of
outcome instruments in patients with this condition
[11]. To our knowledge, two PASS estimates for generic
pain have been published for patients with SAPS [12,
13]. In other shoulder conditions, namely patients
undergoing shoulder arthroplasty [13, 14] and patients
with rheumatoid arthritis who are awaiting surgery [15],
PASS estimates have been published for the American
shoulder and elbow surgeons (ASES) score, the Simple
Shoulder Test (SST), Shoulder Pain and Disability Index
(SPADI), and the Visual Analog Scale (VAS) pain score.
We used the 2-year follow-up data from the FIMP
ACT trial [16] to estimate MID and PASS thresholds for
four common shoulder outcome instruments used with
patients with SAPS. We employed multiple established
methods and data from a relatively large, well estab-
lished, and uniform patient sample. The outcomes in-
cluded three patient reported outcome measures –
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shoulder pain at rest, shoulder pain on arm activity
(both measured using the visual analogue scale) and the
Simple Shoulder Test [17]. The Constant-Murley score
[18] consists of patient-reported and outcome assessor-
measured components.
Materials and methods
Data source and study population
FIMPACT is a randomised, placebo-surgery controlled
three-arm efficacy trial of subacromial decompression
for treating SAPS. The trial was conducted at three
orthopaedic clinics in Finland. One hundred ninety-
three patients aged 35 to 65 years with SAPS were ran-
domised to arthroscopic subacromial decompression
(ASD), diagnostic arthroscopy (DA) or exercise therapy
(ET), and followed for 24 months. At the eligibility
screening visit, an experienced shoulder surgeon exam-
ined the patients to rule out shoulder instability, rotator
cuff rupture, frozen shoulder or other causes of shoulder
symptoms. All potentially eligible participants had stand-
ard x-rays and MRI to rule out rotator cuff rupture and
other shoulder pathology. Baseline characteristics of par-
ticipants are presented in Table S1 in the supplementary
appendix and full details of the study can be found in
the original articles [16, 19].
Data time points
Pain and global rating of change (GRC) were collected at
baseline, 6-, 12- and 24-month follow-ups; SST and
Constant-Murley score were measured at baseline, 6-
and 24-month follow-ups.
Outcome instruments of interest
Pain at rest and pain on arm activity
Shoulder pain intensity during the previous 24 h was
assessed on a 100 mm visual analogue scale (VAS) ran-
ging from 0 (no pain) to 100 (extreme pain) (Fig. S1 in
the supplementary appendix). Pain at rest and on arm
activity were measured separately.
Shoulder function instruments Constant-Murley score and
Simple Shoulder Test
The Constant-Murley score [18] comprises measures of
capacity (range of motion and strength) and subjective pa-
rameters (pain assessment, work load, and leisure time ac-
tivities), which yield a score ranging from 0 (worst) to 100
(best). Although the Constant-Murley score is one of the
most frequently cited instruments, it does not have con-
vincing evidence for its psychometric properties [20].
The Simple Shoulder Test (SST) [17], consists of 12
questions of shoulder status and function, with yes (1)
or no (0) response options. Answers are summed for a
score ranging from 0 to 12, with maximum score indi-
cating normal shoulder function. The Simple Shoulder
Test has good evidence in support of internal
consistency, reliability, structural validity, hypothesis
testing, and responsiveness [20].
Global rating of change
Participants were asked their subjective satisfaction to
treatment outcome relative to baseline at the 6-, 12- and
24-month follow-up visits on a five-point global rating
of change (GRC) scale (Table 1).
Data analysis for MID
We used the GRC as the anchor question for calculating
the MID. An adequate transition anchor should correl-
ate to the change in outcome, and ideally correlate
equally, but in opposite directions to the scores of out-
comes at baseline and at follow-up time points (post
scores) [21]. The correlation to change should be larger
than the correlation to post scores when the GRC cap-
tures true change [22]. To explore this, we calculated
the correlation coefficients (Spearman’s rho) for the
GRC answers at different time points and baseline
scores, the GRC and each of the respective post scores
and the post scores of the combined dataset, and the
GRC and the change scores of the outcomes, also at
follow-up time points and the combined dataset. 95%
CIs were calculated by bootstrapping 1000 samples for
the correlations between the anchor and relevant scores.
We used three approaches to determine the MID for
improvement: 1) the ROC method, 2) the mean differ-
ence of change (MDoC) method and 3) the mean change
(MC) method.
For the ROC method [23], we dichotomised the GRC
to improved (responses 1–3; Table 1) and no change (re-
sponse 4; Table 1). Participants with response worse (re-
sponse 5; Table 1) were excluded from the ROC
analyses to obtain MID estimates for improvement [24].
Because very few patients deteriorated, we could not es-
timate MIDs for worsening. We used the closest point
to top left corner method to choose the cut-off value for
the outcome, maximising specificity and sensitivity [25].
For the target measures, we calculated change from
baseline to each follow-up point.
Table 1 Global Rating of Change response optionsa
1. Very satisfied—my shoulder has healed completely.
2. Satisfied—I have only minor, activity related symptoms. My shoulder
is much better than before treatment.
3. Somewhat satisfied—I have only minor symptoms. My shoulder is
better than before treatment.
4. Dissatisfied—my shoulder is the same as before treatment.
5. Very dissatisfied—my shoulder is worse than before treatment.
aParticipants were instructed to choose the answer that best represented their
current situation. The answer options 1–5 have been translated from Finnish
to English
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To evaluate how well each measure could discriminate
between those who were improved and those who were
not improved, we calculated the area under the ROC
curve (AUC). We determined the confidence intervals
for AUC using DeLong’s method [26]. The area ranges
from 0.5 (no accuracy in distinguishing improved from
not improved) to 1.0 (perfect accuracy) [27, 28]. In mus-
culoskeletal conditions, AUC values between 0.7 and 0.8
are acceptable, and value greater than 0.8 is considered
to have good to excellent discrimination [29].
In the MDoC method, we calculated the mean differ-
ence of the change scores of each outcome from baseline
to the follow-up time point (with 95% CIs) between the
participants who answered” Somewhat satisfied” and”
Dissatisfied” (responses 3 and 4; Table 1). In the MC
method, we determined the mean of the change scores
from baseline to the follow-up time points (with 95%
CIs) of those who reported” Somewhat satisfied” (re-
sponse 3; Table 1). With the MDoC and MC methods,
the 95% CIs were calculated by bootstrapping 1000 sam-
ples for the MID values.
We combined the data across all time points (6, 12,
24 months) and used the whole dataset irrespective of
treatment for analyses to provide an estimate derived
from a larger number of GRC-outcome pairs. We ex-
plored the ROC curves, and MID and PASS estimates at
different time points and found them to be very similar,
supporting our decision to pool data for our primary
analysis. To explore whether the different treatments af-
fected the MIDs, we performed sensitivity analyses and
calculated MIDs for patients who underwent surgery
(ASD and DA groups combined) and for patients who
received exercise therapy. In the FIMPACT trial, the
blinding between ASD and DA held well, and the pa-
tients in both ASD and DA groups subjectively under-
went “surgical treatment”.
Data analysis for PASS
For PASS, we used the ROC and the 75th percentile [30]
methods for the combined dataset. The ROC method
was used similarly as in MID. We used the closest point
to top left corner method [25] to determine the cut-off
point and the AUCs were used to evaluate how well
each measure could discriminate between participants
who reported “Very satisfied, my shoulder has healed
completely” and the rest of the cohort (responses 2–5,
Table 1). In 75th percentile method, PASS was defined
as the 25th percentile score for Constant-Murley score
and Simple Shoulder Test, and 75th percentile score for
pain VASs from the distribution of the patients who an-
swered: “Very satisfied, my shoulder has healed com-
pletely”. Because the choice whether to use GRC 1 only
or both 1 and 2 is debatable, we also calculated the
PASS thresholds between participants who reported
“Very satisfied, my shoulder has healed completely” and
“Satisfied—I have only minor, activity related symptoms.
My shoulder is much better than before treatment.” (re-
sponses 1–2, Table 1) and the rest of the cohort (re-
sponses 3–5, Table 1).
Compliance with research ethics standards
This study was conducted in compliance with good clin-
ical practice, and the Declaration of Helsinki.
Results
We analysed data from 193 patients. Due to missing data
items, the number of available GRC-outcome pairs var-
ied at each time point (Table 2).
To test the adequacy of our transition anchor, we cal-
culated the correlations to the baseline values and out-
comes at each time point. The correlations between the
GRC and baseline values were close to zero (Table S2 in
the supplementary appendix). The correlations between
the GRC and post scores in the combined data were for
pain at rest − 0.57 (− 0.63 to − 0.50), for pain on activity
− 0.63 (− 0.69 to − 0.56), for Constant-Murley score 0.63
(0.55 to 0.69) and for Simple Shoulder Test 0.62 (− 0.55
to 0.69). The correlations between the GRC and change
scores in the combined data were for pain at rest − 0.25
(− 0.32 to − 0.16), for pain on activity − 0.53 (− 0.59 to −
0.47), for Constant-Murley score 0.57 (0.49 to 0.64) and
for Simple Shoulder test 0.49 (0.40 to 0.57). The correla-
tions to post scores and change scores at individual time
points are presented in Table S2 in the supplementary
appendix. The correlation between GRC and change of
pain at rest was very low, whereas the correlations be-
tween the GRC and change of other outcomes were ad-
equate. The correlations to post scores were larger than
the correlations to change.
MID estimates
MIDs based on receiver operating characteristic method
MID estimates from the ROC analysis with their charac-
teristics are presented in Table 3. In the ROC analysis,
MID for Constant-Murley score had excellent discrimin-
ation (AUC), while MIDs for pain on arm activity and
SST showed good discrimination. Discrimination im-
proved with the follow-up time (Table S3 in the supple-
mentary appendix). MID for pain at rest did not
discriminate well. The ROC curves are presented in Fig.
S2 in the supplementary appendix.
MIDs based on mean difference of change and mean
change methods
MIDs with 95% CIs based on the MDoC and MC
methods are presented in Table 4. MID values with 95%
CIs from data at each timepoint can be found in the
Table S4 in the supplementary appendix.
Kanto et al. BMC Medical Research Methodology           (2021) 21:45 Page 4 of 9
MID values calculated by the MDoC and MC methods
were larger than the MID values from the ROC analysis,
especially for the Constant-Murley score by a factor of
two: In the primary analysis 9.5 points with ROC
method; 23 points with MDoC method; 24 points with
MC method. Similar results were obtained in the ana-
lyses of separate time points. The estimates of MID
values calculated from data of patients who underwent
surgery were similar to MIDs derived from patients who
received exercise therapy, but the confidence intervals
were wide and the ROC curves were not ideal, making
these subgroup results unreliable.
PASS estimates
Estimates for PASS derived by the ROC and the 75th
percentile methods are presented in Table 5. The AUCs
had acceptable to good discrimination. The ROC curves
are presented in Fig. S3 in the supplementary appendix.
The PASS estimates provided by the 75th percentile
method were almost identical to the values from the
ROC analysis.
Discussion
Our MID estimates for pain on arm activity, the
Constant-Murley score, and the Simple Shoulder Test
appear trustworthy: In the ROC analysis they showed
good (pain on arm activity and Simple Shoulder Test) or
excellent (Constant-Murley score) discrimination be-
tween patients who considered themselves improved or
not improved. The correlations to change scores were
adequate for these three outcomes, but the correlations
to post scores were slightly larger than the correlations
to change scores. MID values derived for pain at rest do
not appear useful in this patient population. When inter-
preting trial results, the smallest credible estimate from
different methods for MID sets the low limit for the MID,
as changes smaller than the smallest MID estimate are
very unlikely to be important to patients. The likely best
MID estimates were 20mm for pain VAS on arm activity,
10 points for Constant-Murley score and 1.5 points for
Simple Shoulder Test.
The PASS estimates using GRC 1 answer only for pain
on arm activity (9 mm), Constant-Murley score (81
points), and Simple Shoulder Test (11 points) were con-
sistent between methods and showed good discrimin-
ation. Using GRC answers 1 + 2, the PASS estimates
were also consistent between methods and the AUCs
were better or similar to the analysis using answer op-
tion 1 only. The PASS estimates with GRC 1 + 2 were 8
for pain at rest, 26 for pain on arm activity, 69 for the
Constant-Murley score and 9 for the Simple Shoulder
Test. We recommend using more conservative of the es-
timates for PASS values, which we think certainly repre-
sents a state of being well.
In line with previous findings [3, 4], our analysis based
on the FIMPACT trial data found high variability of the
MID estimates both between methods and outcome in-
struments. These findings showcase the challenges of
the MID concept and highlight the need for deep under-
standing of the instruments, statistical methods, and dif-
ferences in patient populations when applying the MID
results in clinical practice.
Strengths and weaknesses of the study
We used multiple established methods to estimate the
MID and PASS values in a relatively large patient sample
with high adherence to follow-up (92% at 24 months).
Our study population was exceptionally well established
and uniform: a robust clinical examination by highly ex-
perienced orthopaedic surgeons ensured that partici-
pants had clinical findings consistent with SAPS, and
magnetic resonance imaging with intra-articular contrast
agent (MRA) was used to exclude other shoulder
Table 2 Numbers of data pairs
6months 12months 24months Combined
Pain at rest 179 176 184 539
Pain on arm activity 179 175 184 538
Constant-Murley score 179 – 179 358
Simple Shoulder Test 179 – 180 359
- denotes that outcomes were not measured at the time point
Table 3 MID estimates from the ROC analysis
Outcome measure MID Sensitivity Specificity AUC (95% CI)
Pain at rest (VAS 0–100) 13 0.63 0.72 0.72 (0.64 to 0.81)
Pain on arm activity (VAS 0–100) 20 0.90 0.78 0.86 (0.82 to 0.91)
Constant-Murley score (0–100) 10 0.90 0.89 0.94 (0.92 to 0.97)
Simple Shoulder Test (0–12) 1.5 0.83 0.78 0.87 (0.82 to 0.92)
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pathology. The strict inclusion criteria may limit the
generalisability of our results to other shoulder
conditions.
The anchor question we used for determining the
PASS was not verbatim the recommended PASS ques-
tion [31]. The FIMPACT trial was initiated prior to the
publication of the PASS concept and the recommended
anchor question, forcing us to use the best available
PASS anchor. The choice between GRC 1 and 1 + 2 to
represent a satisfied patient is not clear, so we calcu-
lated the PASS values for both choices. We recommend
the PASS estimates calculated with GRC answer 1 only,
thinking that erring on the side of caution would be the
wise choice here. While acknowledging that our choice
can provide a conservative threshold for PASS, we are
confident that patients are satisfied with a “completely
healed shoulder” and that this response option truly
represents a state of being well.
Given the relatively long interval between the baseline
and first follow-up, risk of recall bias is obvious. This
notion is supported by very low correlations between the
transition item and baseline and lower correlations to
change scores than to the post scores [21, 22]. This is an
inherent weakness of the GRC in a setting where the
condition needs longer to evolve than a reliable recall
time frame [22]. The AUCs generated by the ROC
method had good to excellent discrimination. Also, each
of the GRC response options contained a description of
satisfaction to the change (and some also a statement of
state) and this could affect patient responses compared
to a pure satisfaction or change questions. However, the
patients were very symptomatic at the baseline, and we
think that the answer options capture change in their
wording, and the best category also represents a satisfac-
tory state.
Comparison to previous studies
The method of determining MID affected the values in
our study [3, 4]. The lowest cut-offs were obtained with
the ROC method (20 mm for pain on arm activity, 10
points for Constant-Murley score and 1.5 points for
Simple Shoulder Test) and the highest with the MC
method (26, 23, and 2.7, respectively).
A recent systematic review of anchor-based MIDs for
improvement in patient-reported outcomes provided
MID estimates for mixed shoulder conditions [11].
There was large variation in reported values between
studies. The median estimate for MID concerning pain
at rest measured with VAS was 30mm and for pain
VAS on arm activity was 21 mm [11]. Our MID estimate
Table 4 MID estimates from the mean difference of change
(MDoC) and mean change (MC) analyses
Outcome measure Method MID (95% CI)
Pain at rest (VAS 0–100) MDoC 16 (7 to 27)
MC 23 (18 to 27)
Pain on arm activity (VAS 0–100) MDoC 24 (14 to 34)
MC 26 (20 to 32)
Constant-Murley score (0–100) MDoC 24 (18 to 31)
MC 23 (19 to 27)
Simple Shoulder Test (0–12) MDoC 2.3 (1.4 to 3.3)
MC 2.7 (2.1 to 3.3)
Table 5 PASS estimates
Outcome measure 75th percentile method ROC method
PASS PASS Sens Spec AUC (95% CI)
Pain at rest (VAS 0–100)
GRC answer 1 2 2 0.71 0.69 0.74 (0.70 to 0.79)
GRC answers 1 + 2 6 8 0.79 0.75 0.83 (0.79 to 0.86)
Pain on arm activity (VAS 0–100)
GRC answer 1 10 9 0.80 0.75 0.83 (0.79 to 0.88)
GRC answers 1 + 2 29 26 0.73 0.77 0.82 (0.78 to 0.86)
Constant-Murley score (0–100)
GRC answer 1 80 81 0.73 0.74 0.78 (0.73 to 0.83)
GRC answers 1 + 2 71 69 0.81 0.75 0.85 (0.80 to 0.89)
Simple Shoulder Test (0–12)
GRC answer 1 11 11 0.68 0.81 0.80 (0.75 to 0.85)
GRC answers 1 + 2 9 9 0.81 0.70 0.83 (0.78 to 0.87)
GRC answer 1: Very satisfied—my shoulder has healed completely
GRC answer 2: Satisfied—I have only minor, activity related symptoms. My shoulder is much better than before treatment
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for pain VAS on arm activity is in line with the system-
atic review [11], but there is a marked difference in MID
estimates for pain at rest. In our study, change scores of
pain VAS at rest did not show adequate correlation with
the anchor question and the AUCs in the ROC analysis
were low, which in our opinion aligns well with the clin-
ical reality that pain at rest is rarely the predominant
symptom driving patients with SAPS to seek medical at-
tention. The MID estimate for Constant-Murley score
was 8.3 points in the systematic review, which is very
similar to our estimate (10 points). The median estimate
for SST was 1.8 points [11], again consistent with our re-
sult of 1.5 points. Another recent systematic review [32]
identified two studies that had assessed MID estimates
for Constant-Murley score in patients with rotator cuff
tears. The MID estimates were 8 to 10 points.
We identified two studies that attempted to determine
PASS estimates for VAS or numeric pain rating scale
(NPRS) of patients treated for subacromial pain. Tubach
et al. [12] reported PASS estimates for VAS ranging
from 16 to 24mm in patients treated nonoperatively for
“acute rotator cuff syndrome.” Tashjian et al. [13] re-
ported a PASS estimate of 30 mm for shoulder pain VAS
for patients with rotator cuff disease treated without sur-
gery. Neither study reported separate values for pain at
rest or pain on arm activity. Nevertheless, our recom-
mended estimates are markedly lower, probably due to
use of only the “very satisfied, completely healed” cat-
egory as the anchor for PASS.
We were not able to identify studies reporting PASS
estimates for Constant-Murley score or Simple Shoulder
Test in patients with subacromial pain syndrome.
Meaning of the study
The smallest trustworthy estimate from different
methods for MID can be used because anything less
than the smallest MID estimate should be interpreted as
unimportant to the patient. There may be settings where
using the highest estimate is useful, for example, in a su-
periority trial where there is a large difference between
treatments the higher limit for MID might be a good
choice as a threshold for “unequivocal effectiveness.”. In
our study, the ROC method provided the smallest esti-
mates and discriminated well between those who consid-
ered themselves improved from those not improved.
Pain at rest showed poor correlation with the anchor
question and change score and low ability to discrimin-
ate, reflecting its low usefulness in this patient
population.
Our PASS estimates for pain at rest and pain on arm
activity, Constant-Murley score, and Simple Shoulder
Test were consistent across methods and showed good
to excellent discrimination between those who consid-
ered themselves well from those who did not. We chose
to recommend using the estimates derived from analysis
using GRC answer 1 only, but it is likely to be conserva-
tive, as the acceptable symptoms state may include some
minor symptoms also. When the PASS estimates are used
to interpret study results, depending on the study setting
and characteristics of the patient population, the estimates
derived using GRC 1 + 2 can be applicable as well.
Unanswered questions and future research
The MID estimates vary widely, depending on assessment
methods and patient populations [33]. Change appears to
be baseline dependent: people with more severe symptoms
need to experience a greater change to consider their con-
dition improved [30, 34] and the results are sensitive to
the time point and anchor questions used. Future research
topics include determining and then standardising the
best method(s) – including the anchor question – for esti-
mating the MID. Qualitative approaches might also have a
place in future research [35].
Conclusion
Different methods provided different estimates for
MIDs. We recommend MID estimates for patients with
subacromial pain as follows: 20 mm for pain VAS on
arm activity, 10 points for Constant-Murley score and
1.5 points for Simple Shoulder Test. We could not es-
tablish a reliable MID for changes in pain at rest in this
patient population. We recommend PASS estimates of 9
mm for pain on arm activity, 80 points for Constant-
Murley score, and 11 points for Simple Shoulder Test.
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